A mobile health application for prostate cancer antigen dosage: is it time to say goodbye to classic screening methods?
Journal
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
ISSN: 1473-5709
Titre abrégé: Eur J Cancer Prev
Pays: England
ID NLM: 9300837
Informations de publication
Date de publication:
30 Nov 2023
30 Nov 2023
Historique:
medline:
5
12
2023
pubmed:
5
12
2023
entrez:
5
12
2023
Statut:
aheadofprint
Résumé
To evaluate the quality of apps for prostate cancer antigen (PSA) dosage, available for downloading on the iOS and Android platforms, discussing the potential role of mobile health applications (MHAs) in update the screening protocol. An observational cross-sectional descriptive study of all smartphone apps for PSA dosage was performed through the most used platforms (iOS and Android). On 10 February 2023, a total of 457 apps were found according to the search criteria. Mobile Application Rating Scale (MARS) was adopted to assess apps' quality. Then, MARS items were analyzed through descriptive statistics and bivariate correlations between study variables with Pearson's coefficient. Of all samples, 24 MHAs were included in the final analysis: 12% (n = 3) from the iTunes App Store and 88% (n = 21) from the Google Play Store. According to the MARS quality assessment, the mean values 2.61, 2.94, 3.11, 2.97, 2.94, and 2.63 were measured for the engagement, functionality, aesthetics, information, overall mean score, and subjective quality, respectively. The MHAs for PSA were under the acceptability threshold and future improvements are required. Moreover, MHAs appropriately developed could play an active role in PSA screening campaign and adherence of follow-up regimens. Finally, the virtual instrument could both reduce the social divide of access to care for patients in rural areas and improve PCA detection, speeding up the active treatment.
Identifiants
pubmed: 38051582
doi: 10.1097/CEJ.0000000000000845
pii: 00008469-990000000-00118
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Al-Dboush R, Al-Zawawi E, El-Bialy T (2023). Does motivation via a smartphone application improve oral hygiene in patients undergoing orthodontic treatment? Evid Based Dent.
Arakawa Y, Haseda M, Inoue K, Nishioka D, Kino S, Nishi D, et al. (2023). Effectiveness of mHealth consultation services for preventing postpartum depressive symptoms: a randomized clinical trial. BMC Med 21:221.
Barbosa AI, Wichers JH, van Amerongen A, Reis NM (2017). Towards one-step quantitation of Prostate-Specific Antigen (PSA) in microfluidic devices: feasibility of optical detection with nanoparticle labels. BioNanoScience 7:718–726.
Bergroth R, Matikainen M, Rannikko A (2021). Mobile PSA: a novel telehealth tool for prostate cancer follow-up. Eur Urol Open Sci 28:43–46.
Blebil AQ, Dujaili JA, Mohammed AH, Loh LL, Chung WX, Selvam T, et al. (2023). Exploring the ehealth literacy and mobile health application utilisation amongst Malaysian pharmacy students. J Telemed Telecare 29:58–71.
Brimley S, Natale C, Dick B, Pastuszak A, Khera M, Baum N, et al. (2021). The emerging critical role of telemedicine in the urology clinic: a practical guide. Sex Med Rev 9:289–295.
Cirillo L, Manfredi C, Barone B, Morgera V, Cacace G, Mastrangelo F, et al. (2023). Mobile health applications in kidney stone disease management: a reliable support for patients? Arch Ital Urol Androl 95:11076.
Creta M, Sagnelli C, Celentano G, Napolitano L, La Rocca R, Capece M, et al. (2021). SARS-CoV-2 infection affects the lower urinary tract and male genital system: a systematic review. J Med Virol 93:3133–3142.
Creta M, Manfredi C, Arcaniolo D, De Sio M, Longo N, De Nunzio C, et al. (2023). Mobile health: a promising tool for the management of male patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1:3.
Di Bello F, Di Mauro E, Collà Ruvolo C, Creta M, La Rocca R, Celentano G, et al. (2022). Immunotherapy for urological tumors on YouTubeTM: an information-quality analysis. Vaccines (Basel) 11:92.
Di Mauro E, Di Bello F, Califano G, Morra S, Creta M, Celentano G, et al. (2023). Incidence and predicting factors of histopathological features at robot-assisted radical prostatectomy in the mpmri era: results of a single tertiary referral center. Medicina (Kaunas) 59:625.
EAU Guidelines: Prostate Cancer (2021). Uroweb. https://uroweb.org/guideline/prostate-cancer/. [citato 13 giugno 2021].
Fusco GM, Cirillo L, Abate M, Morra S, Morgera V, Barone B, et al. (2022). Male infertility, what mobile health applications «know»: quality analysis and adherence to European Association of Urology Guidelines. Arch Ital Urol Androl 94:470–475.
Jupp JCY, Sultani H, Cooper CA, Peterson KA, Truong TH (2018). Evaluation of mobile phone applications to support medication adherence and symptom management in oncology patients. Pediatr Blood Cancer 65:e27278.
Kiciak A, Clark W, Uhlich M, Letendre A, Littlechild R, Lightning P, et al. (2023). Disparities in prostate cancer screening, diagnoses, management, and outcomes between Indigenous and non-Indigenous men in a universal health care system. Cancer 129:2864–2870.
Li H, Cai Q, Wang J, Jie G (2023). Versatile FeMoOv nanozyme bipolar electrode electrochemiluminescence biosensing and imaging platform for detection of H2O2 and PSA. Biosens Bioelectron 232:115315.
Lukas H, Xu C, Yu Y, Gao W (2020). Emerging Telemedicine Tools for Remote COVID-19 Diagnosis, Monitoring, and Management. ACS Nano 14:16180–16193.
Mirone V, Creta M, Capece M, Celentano G, Califano G, Collà Ruvolo C, et al. 2021a). Telementoring for communication between residents and faculty physicians: results from a survey on attitudes and perceptions in an Academic Tertiary Urology Referral Department in Italy. Arch Ital Urol Androl 93:450–454.
Mirone V, Napolitano L, D’Emmanuele di Villa Bianca R, Mitidieri E, Sorrentino R, Vanelli A, et al. 2021b). A new original nutraceutical formulation ameliorates the effect of Tadalafil on clinical score and cGMP accumulation. Arch Ital Urol Androl 93:221–226.
Mirone V, Celentano G, Collà Ruvolo C, Cirillo L, Fusco GM, Abate M, et al. (2022). Perceptions and attitudes toward the use of telemedicine for the postoperative outpatient urological care during the COVID-19 pandemic in an Academic Hospital in Southern Italy. Arch Ital Urol Androl 94:375–379.
Mirone V, Abate M, Fusco GM, Cirillo L, Napolitano L, Morra S, et al. (2023). Telemedicine and YouTubeTM: video quality analysis before and after COVID-19 pandemic. Arch Ital Urol Androl 95:11341.
Morra S, Napolitano L, Collà Ruvolo C, Celentano G, La Rocca R, Capece M, et al. (2022). Could YouTubeTM encourage men on prostate checks? a contemporary analysis. Arch Ital Urol Androl 94:285–290.
Napolitano L, Fusco GM, Cirillo L, Abate M, Mirone C, Barone B, et al. 2022a). Erectile dysfunction and mobile phone applications: quality, content and adherence to European Association guidelines on male sexual dysfunction. Arch Ital Urol Androl 94:211–216.
Napolitano L, Cirillo L, Fusco GM, Abate M, Falcone A, Morgera V, et al. 2022b). Premature ejaculation in the era of mobile health application: a current analysis and evaluation of adherence to EAU guidelines. Arch Ital Urol Androl 94:328–333.
Napolitano L, Cirillo L, Fusco GM, Abate M, Morgera V, Cacace G, et al. 2022c). Natural treatments for erectile dysfunction: a focus on mobile health applications. Arch Ital Urol Androl 94:373–374.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71.
Rabinowitz MJ, Kohn TP, Ellimoottil C, Alam R, Liu JL, Herati AS (2021). the impact of telemedicine on sexual medicine at a major academic center during the COVID-19 pandemic. Sex Med 9:100366.
Sageena G, Sharma M, Kapur A (2021). Evolution of smart healthcare: telemedicine during COVID-19 pandemic. Int J Environ Res Public Health 102:1319–1324.
Samadbeik M, Bastani P, Fatehi F (2022). Bibliometric analysis of COVID-19 publications shows the importance of telemedicine and equitable access to the internet during the pandemic and beyond. Health Info Libr J.
Stoyanov SR, Hides L, Kavanagh DJ, Zelenko O, Tjondronegoro D, Mani M (2015). Mobile app rating scale: a new tool for assessing the quality of health mobile apps. JMIR MHealth UHealth 3:e27.
Tabira K, Ohwatashi A (2023). Empirical study on the effectiveness of online groups using a mobile health application for middle-aged and older adults to continue exercising. J Phys Ther Sci 35:346–350.